Cam Patterson, M.D., M.B.A., is the senior Vice President and Chief Operating Officer of NewYork-Presbyterian Hospital/Weill-Cornell Medical Center in New York. He was previously Physician-in-Chief of the UNC Center for Heart and Vascular Care, the Chief of the Division of Cardiology, and the
…
more Director of the McAllister Heart Institute at the University of North Carolina at Chapel Hill. Dr. Patterson supervised a clinical program with over 60 cardiologists, surgeons, and radiologists, as well as a research program of 30 principal investigators from clinical and basic science departments.
Dr. Patterson research interests are in the areas of angiogenesis and vascular development, cardiac hypertrophy, protein quality control, and translational genomics and metabolomics. His major research accomplishments include the characterization of the role of ubiquitin ligases and protein quality control mechanisms in cardiac structure and function; the discovery of transcriptional mechanisms that determine endothelial cell specification; and discovery and biochemical characterization of stress-dependent ubiquitin ligases such as CHIP. Dr. Patterson is the founder of two biotechnology companies, Dyzen Inc. and Enci Therapeutics. He serves on numerous editorial boards, including Circulation, Circulation Research, Molecular and Cellular Biology, and the Journal of Clinical Investigation.
Recent honors for Dr. Patterson include the Ruth and Phillip Hettleman Prize for Artistic and Scholarly Achievement, the Established Investigator Award of the American Heart Association and the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research. He is an elected member of the ASCI, the Association of American Physicians, the Association of University Cardiologists, and the American Clinical and Climatological Association.
less